Company profile
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was
- CEO
- Mr. Jun Liu
- Headquarters
- Jericho, NY, United States
- Employees
- 6
- IPO date
- Aug 26, 2025
- Sector
- Healthcare
- Industry
- Biotechnology